Quantum BioPharma Ltd.

About Quantum BioPharma Ltd.

Quantum BioPharma is a biopharmaceutical company focused on advancing science and saving lives by developing innovative therapies for neuro disorders, brain, and inflammatory disorders. Their mission is to create novel solutions, with a vision to be a world-class innovation-driven company improving patients' quality of life through commitment, hard work, and integrity.

Products & Services

UNBUZZD™:A revolutionary rapid alcohol detoxification drink launching in 2024, designed to support mental alertness and detoxification after alcohol consumption. It is a science-backed beverage aimed at helping people feel refreshed and balanced after social drinking, developed by a team of scientists and former executives from Coca-Cola and Celsius Holdings.

LUCID-MS:A patented neuroprotective compound (New Chemical Entity) for Multiple Sclerosis and other neurodegenerative diseases. It prevents and reverses myelin degradation, showing excellent efficacy in preclinical models. Phase-1 clinical trials for safety and tolerability have been completed with healthy volunteers.

Specialties

Neurodegenerative disease therapies Neuropsychiatric disease treatments Myelin repair compounds Functional beverages for detoxification Multiple Sclerosis research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 40000 MR: - FA: US$40,000.00 FAN: 40000	D: 2025-07-22 FD: 2025-07-22	1 investors
2	RT: Private Placement T: - FT: Private Placement	A: 600 MR: - FA: up to $600 FAN: 600	D: 2025-06-27 FD: 2025-06-27	2 investors
3	RT: Debt T: - FT: Debt	A: 5000000 MR: - FA: $5 million FAN: 5000000	D: 2025-03-31 FD: 2025-03-31	-
4	RT: Debt T: - FT: Debt	A: 500000 MR: - FA: $500,000 FAN: 500000	D: 2024-12-20 FD: 2024-12-20	-
5	RT: Debt T: - FT: Debt	A: 500000 MR: - FA: $500,000 FAN: 500000	D: 2024-12-13 FD: 2024-12-13	-
6	RT: Debt (Convertible Debenture) T: - FT: Debt (Convertible Debenture)	A: 5000000 MR: - FA: Up to $5,000,000 FAN: 5000000	D: 2024-12-05 FD: 2024-12-05	-

Debt Latest

2025-07-22

$40K

1 investor (Pro only)

Private Placement 2025-06-27

$600

Debt 2025-03-31

$5.0M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Chris Tyson

Executive Vice President

J

Jason Sawyer

Head of Finance and M&A

D

Donal Carroll

Chief Financial Officer

D

Dr. Lakshmi P. Kotra, PhD

President Quantum BioPharma, CEO Quantum BioPharma Australia Pty Ltd

D

Dr. Andrzej Chruscinski, MD, PhD

Vice-President, Clinical and Scientific Affairs

N

Nathan Coyle, CPA

Controller

View 24 more team members with Pro

Unlock Full Team Directory

Recent News